◀ Back to CXCL2
CXCL2 — PTGS2
Text-mined interactions from Literome
Põld et al., Cancer Res 2004
(Carcinoma, Non-Small-Cell Lung...) :
Cyclooxygenase-2 dependent expression of angiogenic
CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer ... To elucidate the
role of
COX-2 in the in vitro and in vivo expression of two known NSCLC angiogenic peptides,
CXC ligand ( CXCL ) 8 and CXCL5, we studied two COX-2 gene modified NSCLC cell lines, A549 and H157 ...
COX-2 overexpression
enhanced the in vitro expression of both
CXCL8 and CXCL5
Hamada et al., J Immunol 2008
(Reperfusion Injury) :
The lack of
COX-2 expression
resulted in decreased levels of
CXCL2 , a neutrophil activating chemokine, reduced infiltration of MMP-9 positive neutrophils, and impaired late macrophage activation in livers after I/R injury
Brant et al., Toxicological sciences : an official journal of the Society of Toxicology 2009
:
Consistent with our previous findings that Ni and MALP-2 stimulates the induction of CXCL8 via a COX-2 mediated pathway,
CXCL1 , CXCL5, and VEGF release were also
regulated by
COX-2